Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Andrew M. Yuan"'
Publikováno v:
ICETC
The Mixed-Reality Integrated Learning Environment (MILE) developed at Florida State University is a virtual reality based, inclusive and immersive e-learning environment that promotes engaging and effective learning interactions for a diversified lea
Publikováno v:
Journal of Medicinal Chemistry. 40:506-514
The design, synthesis, and biochemical profile of meta-substituted benzofused macrocyclic lactams are described. The meta-substituted benzofused macrocyclic lactams were designed to have a degree of flexibility allowing the amide bond to occupy two c
Autor:
L. El‐Chehabi, Mark D. Erion, Andrew M. Yuan, Gary Michael Ksander, Clive Gideon Diefenbacher, D. Cote, N. Levens
Publikováno v:
ChemInform. 25
A variety of compounds were prepared to determine whether dual angiotensin converting enzyme (ACE)/thromboxane synthase (TxS) inhibition could be obtained in the same molecule. These compounds would be used to explore the concept that a dual inhibito
Autor:
David Louis Feldman, Randy L. Webb, Warren Lee, Ashok Hospattankar, Michael Jeune, Alan D. Neubert, Natalie A. Bilci, Natalya Alexander, Andrew M. Yuan, Therese C Mogelesky, Aida E. Navarrete, Gary Michael Ksander, Joyce C. Gibson, Eric Carlson, Haamid M. Sharif, Eli M. Wallace, Jong Wasvery, Reynalda Dejesus, Paivi Jaana Kukkola, Edna Cahill, Michael A. Moskal, Cynthia A. Fink, Steele Ronald Edward, Zouhair F. Stephan, Kevin Poirier
Publikováno v:
Journal of medicinal chemistry. 44(26)
The synthesis and biological activities of biarylamide-substituted diaminoindanes as microsomal triglyceride transfer protein (MTP) inhibitors are described. One of the more potent compounds, 8aR, inhibited both the secretion of apoB from Hep G2 cell
Autor:
Carol Berry, Yumi Sakane, Angelo J. Trapani, Clive G. Diefenbacher, Andrew M. Yuan, Gary Michael Ksander, Raj D. Ghai, Reynalda deJesus
Publikováno v:
Journal of medicinal chemistry. 38(10)
The synthesis of three series of dicarboxylic acid dipeptide neutral endopeptidase 24.11 (NEP) inhibitors is described. In particular, the amino butyramide 21a exhibited potent NEP inhibitory activity (IC50 = 5.0 nM) in vitro and in vivo. Blood level
Autor:
D. Cote, Mark D. Erion, Gary Michael Ksander, L. El‐Chehabi, N. Levens, Clive Gideon Diefenbacher, Andrew M. Yuan
Publikováno v:
Journal of medicinal chemistry. 37(12)
A variety of compounds were prepared to determine whether dual angiotensin converting enzyme (ACE)/thromboxane synthase (TxS) inhibition could be obtained in the same molecule. These compounds would be used to explore the concept that a dual inhibito
Autor:
Andrew M. Yuan, Clive G. Diefenbacher, Gary Michael Ksander, Yumi Sakane, R. D. Ghai, F. Clark
Publikováno v:
Journal of Medicinal Chemistry. 32:2519-2526
The synthesis of two new series of dicarboxylic acid dipeptides and two sulfhydryl-containing inhibitors are described. The in vitro enkephalinase inhibition data and some in vivo analgesic data are presented for these compounds. For the dibenzylglut
Publikováno v:
Journal of Medicinal Chemistry. 28:1606-1611
The preparation of two series of N-carbobenzoxy-gamma-D-glutamyl secondary 2S amino acids and (N-substituted gamma-D-glutamyl)indoline-2(S)-carboxylic acid dipeptides is described. In vitro inhibition of angiotensin converting enzyme (ACE) is reporte
Autor:
Frank H. Ebetino, Norbert Gruenfeld, Leslie J. Browne, Candido Gude, Charles F. Huebner, Andrew M. Yuan, James L. Stanton
Publikováno v:
Journal of Medicinal Chemistry. 26:1277-1282
The preparation of a series of 1-glutarylindoline-2(S)-carboxylic acid derivatives, 6a-v and 21a-c, is described. The above compounds were tested for inhibition of angiotensin converting enzyme. The structure-activity relationship of the series is al
Autor:
William Macchia, Robert C. Friedmann, Norbert Gruenfeld, Michael H. Ackerman, Joseph E. Babiarz, Andrew M. Yuan, James L. Stanton
Publikováno v:
Chemischer Informationsdienst. 15
The synthesis of N-(3-mercaptopropionyl)-N-arylglycines (14a-x),- N-arylalanines (15a,b),-N-cycloalkylglycines (16a-k), and -1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids (17a-d), -1,2,3,4-tetrahydroquinoline-2-carboxylic acids (18a-f), and -indo